ENTRY       D08552                      Drug
NAME        Sunitinib (INN)
FORMULA     C22H27FN4O2
EXACT_MASS  398.2118
MOL_WEIGHT  398.4738
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: L01EX01
            Chemical structure group: DG00712
            Product (DG00712): D06402<JP/US>
EFFICACY    Antineoplastic, Angiogenesis inhibitor, Receptor tyrosine kinase inhibitor
TARGET      CSF1R (FMS, CD115) [HSA:1436] [KO:K05090]
            FLT3 (CD135) [HSA:2322] [KO:K05092]
            PDGFR [HSA:5156 5159] [KO:K04363 K05089]
            RET [HSA:5979] [KO:K05126]
            VEGFR1 (FLT1) [HSA:2321] [KO:K05096]
            VEGFR2 (KDR) [HSA:3791] [KO:K05098]
            VEGFR3 (FLT4) [HSA:2324] [KO:K05097]
            KIT (CD117) [HSA:3815] [KO:K05091]
  PATHWAY   hsa04010(1436+2321+2322+2324+3791+3815+5156+5159)  MAPK signaling pathway
            hsa04014(1436+2321+2322+2324+3791+3815+5156+5159)  Ras signaling pathway
            hsa04151(1436+2321+2322+2324+3791+3815+5156+5159)  PI3K-Akt signaling pathway
            hsa04370(3791)  VEGF signaling pathway
            hsa05200(1436+2322+2324+3815+5156+5159+5979)  Pathways in cancer
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07045  Antineoplastics - protein kinase inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EX Other protein kinase inhibitors
                 L01EX01 Sunitinib
                  D08552  Sunitinib (INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG00712  Sunitinib
                 D08552  Sunitinib
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00712  Sunitinib
                 D08552  Sunitinib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               PDGFR family
                PDGFR
                 D08552  Sunitinib (INN)
                KIT (CD117)
                 D08552  Sunitinib (INN)
                FLT3 (CD135)
                 D08552  Sunitinib (INN)
               VEGFR family
                VEGFR1 (FLT1)
                 D08552  Sunitinib (INN)
                VEGFR2 (KDR)
                 D08552  Sunitinib (INN)
                VEGFR3 (FLT4)
                 D08552  Sunitinib (INN)
               RET family
                RET
                 D08552  Sunitinib (INN)
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                CSF1R (FMS, CD115)
                 D08552  Sunitinib (INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08552
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG00712  Sunitinib
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00712  Sunitinib
DBLINKS     CAS: 557795-19-4
            PubChem: 96025237
            PDB-CCD: B49
            LigandBox: D08552
            NIKKAJI: J1.942.549E
ATOM        29
            1   C8x C    18.1300  -13.6500
            2   C8x C    16.9400  -14.3500
            3   C8y C    16.9400  -15.7500
            4   C8x C    18.1300  -16.4500
            5   C8y C    19.3200  -15.7500
            6   C8y C    19.3200  -14.3500
            7   C2y C    20.7200  -16.1700
            8   C5x C    21.4900  -15.0500
            9   N1x N    20.7200  -13.9300
            10  X   F    15.7500  -16.4500
            11  O5x O    22.8900  -15.0500
            12  C2b C    20.7200  -17.5700
            13  C8y C    21.9100  -18.2700
            14  C8y C    21.9100  -19.6700
            15  C8y C    23.2400  -20.0900
            16  C8y C    24.0100  -18.9700
            17  N4x N    23.2400  -17.8500
            18  C1a C    20.7200  -20.5100
            19  C1a C    25.4800  -18.9700
            20  C5a C    23.2400  -21.5600
            21  O5a O    22.0500  -22.2600
            22  N1b N    24.5000  -22.2600
            23  C1b C    25.6900  -21.5600
            24  C1b C    26.8800  -22.2600
            25  N1c N    28.0700  -21.5600
            26  C1b C    29.2600  -22.2600
            27  C1a C    30.4500  -21.5600
            28  C1b C    28.0700  -20.0900
            29  C1a C    29.2600  -19.4600
BOND        31
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     5   7 1
            8     7   8 1
            9     8   9 1
            10    6   9 1
            11    3  10 1
            12    8  11 2
            13    7  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17   15  16 2
            18   16  17 1
            19   13  17 1
            20   14  18 1
            21   16  19 1
            22   15  20 1
            23   20  21 2
            24   20  22 1
            25   22  23 1
            26   23  24 1
            27   24  25 1
            28   25  26 1
            29   26  27 1
            30   25  28 1
            31   28  29 1
///
